Drzyzga, A.; Cichoń, T.; Czapla, J.; Jarosz-Biej, M.; Pilny, E.; Matuszczak, S.; Wojcieszek, P.; Urbaś, Z.; Smolarczyk, R.
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers 2021, 13, 3924.
https://doi.org/10.3390/cancers13163924
AMA Style
Drzyzga A, Cichoń T, Czapla J, Jarosz-Biej M, Pilny E, Matuszczak S, Wojcieszek P, Urbaś Z, Smolarczyk R.
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers. 2021; 13(16):3924.
https://doi.org/10.3390/cancers13163924
Chicago/Turabian Style
Drzyzga, Alina, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Ewelina Pilny, Sybilla Matuszczak, Piotr Wojcieszek, Zbigniew Urbaś, and Ryszard Smolarczyk.
2021. "The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors" Cancers 13, no. 16: 3924.
https://doi.org/10.3390/cancers13163924
APA Style
Drzyzga, A., Cichoń, T., Czapla, J., Jarosz-Biej, M., Pilny, E., Matuszczak, S., Wojcieszek, P., Urbaś, Z., & Smolarczyk, R.
(2021). The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers, 13(16), 3924.
https://doi.org/10.3390/cancers13163924
